Your browser doesn't support javascript.
loading
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.
Koshino, Akihiko; Oshima, Megumi; Arnott, Clare; Fletcher, Robert A; Bakris, George L; Jardine, Meg; Mahaffey, Kenneth W; Perkovic, Vlado; Pollock, Carol; Heerspink, Hiddo J L; Neuen, Brendon L.
Affiliation
  • Koshino A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Oshima M; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.
  • Arnott C; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.
  • Fletcher RA; The George Institute for Global Health, UNSW, Sydney, Australia.
  • Bakris GL; The George Institute for Global Health, UNSW, Sydney, Australia.
  • Jardine M; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Mahaffey KW; The George Institute for Global Health, UNSW, Sydney, Australia.
  • Perkovic V; Department of Medicine, AHA Comprehensive Hypertension Center University of Chicago Medicine, Chicago, Illinois, USA.
  • Pollock C; The George Institute for Global Health, UNSW, Sydney, Australia.
  • Heerspink HJL; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
  • Neuen BL; Concord Repatriation General Hospital, Sydney, Australia.
Diabetes Obes Metab ; 25(5): 1413-1418, 2023 05.
Article in En | MEDLINE | ID: mdl-36655422

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Fatty Liver Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Fatty Liver Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Document type: Article Affiliation country: Country of publication: